Menu
← Oncology Approval Tracker
FDA DECISION ·
Cyclophosphamide Injection
cyclophosphamide · AuroMedics Pharma
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Concentrated injectable cyclophosphamide under a 505(b)(2) NDA for specified oncology uses, including lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, and ovarian, retinal and breast malignancies.
LAMPGEN ANALYSIS
Why it matters
The action adds a liquid presentation of an established alkylating agent across existing cancer uses.
What research teams should watch
Distinguish the concentrate from powder products in pharmacy verification and record indication and preparation instructions.
PRIMARY RECORDS